Communities with limited resources experience a disproportionate burden of respiratory illness due to overlapping social, environmental, and healthcare inequities. Residents are often exposed to harmful factors such as indoor smoke from biomass fuels, poorly regulated occupational environments, and high levels of urban air pollution. At the same time, healthcare services in these areas are frequently underfunded, making access to diagnostic tools, trained specialists, and essential medicines difficult. As a result, preventable conditions such as asthma, chronic obstructive pulmonary disease, and recurrent respiratory infections often go undiagnosed or untreated until they reach advanced stages. The impact of these disparities is especially severe for vulnerable groups such as children, who may develop long-term lung impairment, and older adults, who face higher risks of complications and mortality. The challenge of improving lung health in underserved areas lies not only in addressing medical needs but also in overcoming the social and cultural barriers that delay timely care.
Addressing this issue calls for multi-layered interventions that combine public health initiatives with systemic reforms. Strengthening primary healthcare networks and incorporating community-based workers can expand the reach of diagnostic and treatment services, even in remote locations. Preventive approaches, such as introducing cleaner cooking fuels, expanding immunization programs, and supporting tobacco control, reduce exposure to key risk factors. Education campaigns tailored to local contexts encourage earlier recognition of respiratory symptoms and improve adherence to therapies. Partnerships between governments, NGOs, and research institutions can help ensure affordable medication supply, train local healthcare staff, and generate data for long-term planning. By integrating medical, environmental, and social strategies, sustainable improvements in lung health can be achieved for populations that have long been overlooked.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation